WallStreetZenWallStreetZen

NASDAQ: COEP
Coeptis Therapeutics Holdings Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

COEP past revenue growth

How has COEP's revenue growth performed historically?
Company
N/A
Industry
144.63%
Market
17.55%
COEP's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
COEP's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

COEP earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$21.3M
Current Profit Margin
0%

COEP Return on Equity

Current Company
-738.8%
Current Industry
-63.5%
Current Market
188%
COEP's Return on Equity (-649.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when COEP announces earnings.

COEP Return on Assets

Current Company
-300.2%
Current Industry
2.9%
COEP is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

COEP Return on Capital Employed

Current Company
-416.32%
Current Industry
19.5%
COEP's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

COEP vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
COEP$0.00-$20.16M-$21.27M-100.00%N/A
KPRX$0.00-$12.35M-$13.04M-100.00%N/A
BNOX$14.50kN/A-$20.40M-91.52%+261.25%
PBM$0.00$1.52M$1.52MN/AN/A
MNPR$0.00-$8.40M-$8.40MN/AN/A
View Top Biotech Stocks

Coeptis Therapeutics Holdings Earnings & Revenue FAQ

What were COEP's earnings last quarter?

Coeptis Therapeutics Holdings (NASDAQ: COEP) reported Q4 2023 earnings per share (EPS) of -$0.07, up 333.33% year over year. Total Coeptis Therapeutics Holdings earnings for the quarter were -$3.76 million. In the same quarter last year, Coeptis Therapeutics Holdings's earnings per share (EPS) was $0.03.

If you're new to stock investing, here's how to buy Coeptis Therapeutics Holdings stock.

What was COEP's earnings growth in the past year?

As of Q2 2024, Coeptis Therapeutics Holdings's earnings has grown year over year. Coeptis Therapeutics Holdings's earnings in the past year totalled -$21.27 million.

What was COEP's revenue last quarter?

Coeptis Therapeutics Holdings (NASDAQ: COEP) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Coeptis Therapeutics Holdings's revenue was $0.00.

What was COEP's revenue growth in the past year?

As of Q2 2024, Coeptis Therapeutics Holdings's revenue has grown null year over year. Coeptis Therapeutics Holdings's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.